Severe Acute Generalized Exanthematous Pustulosis Successfully Treated by Spesolimab

Acta Derm Venereol. 2024 Sep 11:104:adv41311. doi: 10.2340/actadv.v104.41311.

Authors

Giuseppe Russo¹, Shireen Dumont², Sébastien Menzinger³, Damien Pastor², Laurence Toutous Trellu², Gürkan Kaya³, Emmanuel Laffitte²

Affiliations

¹ Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland. [email protected].
² Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland.
³ Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland; Department of Clinical Pathology, University Hospital of Geneva, Geneva, Switzerland.

No abstract available

Publication types

Case Reports

MeSH terms

Acute Generalized Exanthematous Pustulosis* / diagnosis
Acute Generalized Exanthematous Pustulosis* / drug therapy
Acute Generalized Exanthematous Pustulosis* / etiology
Acute Generalized Exanthematous Pustulosis* / pathology
Antibodies, Monoclonal, Humanized / adverse effects
Antibodies, Monoclonal, Humanized / therapeutic use
Female
Humans
Male
Severity of Illness Index
Skin / drug effects
Skin / pathology
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized